The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1
Objectives: Doxorubicin (DOXR) belongs to the antineoplastic anthracycline antibiotic and despite its prevalent use for various types of cancer, it is associated with side effects that occur even after treatment cessation, particularly on the heart, blood, liver and kidney. This study aimed to study...
Enregistré dans:
Auteurs principaux: | Ahlam M. Alhusaini, Abeer M. Alanazi, Laila M. Fadda, Qamraa H. Alqahtani, Wedad S. Sarawi, Iman H. Hasan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e7b4f8b1900643a0945d6106ac0f70c4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mokko Lactone Attenuates Doxorubicin-Induced Hepatotoxicity in Rats: Emphasis on Sirt-1/FOXO1/NF-κB Axis
par: Alaa Sirwi, et autres
Publié: (2021) -
Resveratrol in prevention and treatment of common clinical conditions of aging
par: M Andrea Markus, et autres
Publié: (2008) -
Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
par: Zhang L, et autres
Publié: (2019) -
Ferruginol Restores SIRT1-PGC-1α-Mediated Mitochondrial Biogenesis and Fatty Acid Oxidation for the Treatment of DOX-Induced Cardiotoxicity
par: Weili Li, et autres
Publié: (2021) -
Protective Effect of Resveratrol Against Morphine Damage to Kidneys of Mice
par: Jalili,Cyrus, et autres
Publié: (2017)